Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 23,521 | 21,640 | 20,800 | 17,094 | 0 |
| Operating Income | -23,521 | -21,640 | -20,800 | -17,094 | N/A |
| Other Income | 3,541 | 4,103 | 2,679 | -5,575 | 0 |
| Pre-tax Income | -19,980 | -17,537 | -18,121 | -22,669 | 0 |
| Net Income Continuous | -19,980 | -17,537 | -18,121 | -22,669 | N/A |
| Net Income | $-19,980 | $-17,537 | $-18,121 | $-22,669 | $N/A |
| EPS Basic Total Ops | 9.49 | -0.50 | -1.70 | -11.07 | N/A |
| EPS Basic Continuous Ops | 9.50 | -0.50 | -1.70 | -11.07 | N/A |
| EPS Diluted Total Ops | 9.49 | -0.50 | -1.70 | -11.07 | N/A |
| EPS Diluted Continuous Ops | 9.50 | -0.50 | -1.70 | -11.07 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.57 | -0.50 | -1.70 | -11.07 | N/A |
| EBITDA(a) | $-22,701 | $-23,385 | $-21,421 | $-17,920 | $N/A |